Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
出版年份 2012 全文链接
标题
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
作者
关键词
-
出版物
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 39, Issue 5, Pages 406-411
出版商
Wiley
发表日期
2012-01-03
DOI
10.1111/j.1440-1681.2012.05670.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia
- (2014) Pawel P. Dimitrow et al. Pharmacological Reports
- Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease
- (2011) Chang-Wook Nam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation
- (2010) Serdar Bayata et al. Anadolu Kardiyoloji Dergisi-The Anatolian Journal of Cardiology
- Short-Term Treatment with High-Dose Atorvastatin Reduces LDL Cholesterol but Shows no Anti-Inflammatory Effects in Normolipidemic Subjects with Normal CRP Levels
- (2010) John S. Millar et al. CTS-Clinical and Translational Science
- Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
- (2010) Qian Zhang et al. Evidence-based Complementary and Alternative Medicine
- Berberine suppresses proinflammatory responses through AMPK activation in macrophages
- (2009) Hyun Woo Jeong et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Inflammatory Protein Levels and Depression Screening After Coronary Stenting Predict Major Adverse Coronary Events
- (2009) Lorraine Frazier et al. Biological Research for Nursing
- Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease
- (2009) Pan-Pan Hao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Berberine-induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
- (2009) Jie-mei Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages
- (2009) Zhouqing Huang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
- (2009) Hao Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
- (2009) F. Affuso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Impact of lipid lowering therapy on liver function
- (2009) György Paragh et al. ORVOSI HETILAP
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started